{"id":"W2538779678","doi":"10.1212/wnl.80.7_supplement.p07.098","title":"Relapse Outcomes with Alemtuzumab vs IFNB-1a in Active Relapsing-Remitting Multiple Sclerosis Patients Who Experienced Disease Activity While on Prior Therapy (CARE-MS II) (P07.098)","year":2013,"lang":"en","type":"article","venue":"Neurology","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"ca_institutions":"McGill University","funders":"","keywords":"Alemtuzumab; Multiple sclerosis; Relapsing remitting; Medicine; Internal medicine; Disease; Oncology; Immunology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002198851,0.0005996741,0.001574469,0.0003632836,0.0002607492,0.0006675495,0.0004593043,0.0006503865,0.001196552],"category_scores_gemma":[0.0023941,0.0001799811,0.002048426,0.0003850403,0.000330547,0.0004823586,0.0004089571,0.001222693,0.0001837534],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004868569,"about_ca_system_score_gemma":0.0005958583,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001367343,"about_ca_topic_score_gemma":0.002551091,"domain_scores_codex":[0.9989814,0.0006321042,0.00009280632,0.0001032831,0.00008389224,0.0001065731],"domain_scores_gemma":[0.9985951,0.0004287183,0.0004424745,0.00008499141,0.00009073858,0.0003580562],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.8494208,0.004459666,0.08444057,0.0006191058,0.007766866,0.000146175,0.0001845319,0.001061201,0.003694396,0.0001320075,0.001788972,0.0462857],"study_design_scores_gemma":[0.2255285,0.2273427,0.5218987,0.0003469786,0.01525626,0.0004294991,0.0002694961,0.002266392,0.003877355,0.0005112888,0.002199992,0.00007278368],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9964589,0.002584215,0.00002983825,0.0001149155,0.0000362505,0.00004267216,0.000248396,0.000005745582,0.0004790731],"genre_scores_gemma":[0.9984653,0.0005333579,0.00007993299,0.0001256465,0.0001008015,0.0000545586,0.0004580514,0.00000256356,0.0001797849],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002198851,"threshold_uncertainty_score":0.01162875,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04281381609555662,"score_gpt":0.2825410332965076,"score_spread":0.239727217200951,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}